Skip to main content

Dapagliflozin

NDC 70710-1380 · Zydus Pharmaceuticals USA Inc.

Generic nameDapagliflozin
Dosage formTABLET
RouteORAL
Active ingredient(s)DAPAGLIFLOZIN
Strength5 mg/1
Pharmacologic classSodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]
Marketing categoryANDA

Packages

70710-1380-3 — 30 TABLET in 1 BOTTLE (70710-1380-3)

70710-1380-9 — 90 TABLET in 1 BOTTLE (70710-1380-9)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

62332-393 — DAPAGLIFLOZIN, 63304-026 — Dapagliflozin and Metformin Hydrochloride, 63304-027 — Dapagliflozin and Metformin Hydrochloride, 63304-028 — Dapagliflozin and Metformin Hydrochloride, 67877-608 — Dapagliflozin, 67877-609 — Dapagliflozin, 67877-619 — dapagliflozin and metformin hydrochloride, 67877-620 — dapagliflozin and metformin hydrochloride, 67877-621 — dapagliflozin and metformin hydrochloride, 67877-622 — dapagliflozin and metformin hydrochloride, 70710-1381 — Dapagliflozin, 70748-101 — DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE, 70748-102 — DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE, 70748-103 — DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE, 70748-104 — DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE, 70748-105 — Dapagliflozin, 70748-106 — Dapagliflozin, 70771-1714 — Dapagliflozin, 70771-1715 — Dapagliflozin, 70954-856 — Dapagliflozin, +40 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels